Arteaga, C. L. (2003). Trastuzumab, an appropriate first-line single-agent therapy for HER2-overexpressing metastatic breast cancer. BioMed Central.
Style de citation ChicagoArteaga, Carlos L. Trastuzumab, an Appropriate First-line Single-agent Therapy for HER2-overexpressing Metastatic Breast Cancer. BioMed Central, 2003.
Style de citation MLAArteaga, Carlos L. Trastuzumab, an Appropriate First-line Single-agent Therapy for HER2-overexpressing Metastatic Breast Cancer. BioMed Central, 2003.
Attention : ces citations peuvent ne pas être correctes à 100%.